Pentostatin-induced hypereosinophilia with eosinophilic gastroenteritis

Leukemia and Lymphoma

Volumn 51, Issue 8, 2010, Pages 1567-1569

  Shouval, Roni ^a   Duffield, Amy ^b   Gocke, Christopher ^b   Lee, Linda ^c   Brodsky, Robert A ^a  

^a Department of Medicine   (United States)

^b Department of Pathology ^*  (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD103 ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN; COTRIMOXAZOLE; DOLASETRON MESILATE; GLYCOPROTEIN P 15095; INTERLEUKIN 2 RECEPTOR ALPHA; OMEPRAZOLE; PENTOSTATIN;

ABDOMINAL PAIN; ADULT; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CASE REPORT; CHEMOPROPHYLAXIS; DRUG WITHDRAWAL; DUODENITIS; EOSINOPHIL COUNT; EOSINOPHILIC GASTROENTERITIS; ESOPHAGOGASTRODUODENOSCOPY; FATIGUE; FEMALE; GASTROINTESTINAL BIOPSY; HAIRY CELL LEUKEMIA; HEARTBURN; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPEREOSINOPHILIA; IMMUNOHISTOCHEMISTRY; LETTER; MULTIPLE CYCLE TREATMENT; NAUSEA; PANCYTOPENIA; PENUMOCYSTIS PNEUMONIA; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADULT; ANTINEOPLASTIC AGENTS; EOSINOPHILIA; GASTROENTERITIS; HUMANS; LEUKEMIA, HAIRY CELL; MALE; PENTOSTATIN; TREATMENT OUTCOME;

EID: 77955439216     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2010.486879     Document Type: Letter

References (11)

1. Klein NC, Hargrove RL, Sleisenger MH, Jeffries GH. Eosinophilic gastroenteritis. Medicine (Baltimore) 1970;49:299-319.
2. Talley NJ, Shorter RG, Phillips SF, Zinsmeister AR. Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut 1990;31:54-58.
3. Else M, Dearden CE, Matutes E, et al. . Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis. Br J Haematol 2009;145:733-740.
4. Flinn IW, Kopecky KJ, Foucar MK, et al. . Long-term followup of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin. Blood 2000;96:2981-2986.
5. Grever MR, Zinzani PL. Long-term follow-up studies in hairy cell leukemia. Leuk Lymphoma 2009;50(Suppl 1.):23-26.
6. Piro LD, Carrera CJ, Carson DA, Beutler E. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 1990;322:1117-1121.
7. Mann GJ, Fox RM. Deoxyadenosine triphosphate as a mediator of deoxyguanosine toxicity in cultured T lymphoblasts. J Clin Invest 1986;78:1261-1269.
8. Beutler E. Cladribine (2-chlorodeoxyadenosine). Lancet 1992;340:952-956.
9. O'Dwyer PJ, King SA, Eisenhauer E, Grem JL, Hoth DF. Hypersensitivity reactions to deoxycoformycin. Cancer Chemother Pharmacol 1989;23:173-175.
10. Robak T, Blasińska-Morawiec M, Krykowski E, et al. 2-Chlorodeoxyadenosine (cladribine)-related eosinophilia in patients with lymphoproliferative diseases. Eur J Haematol 1997;59:216-220.
11. Oh HE, Chetty R. Eosinophilic gastroenteritis: a review. J Gastroenterol 2008;43:741-750.